FDA approves blood test method for colon cancer screening
The Food and Drug Administration (FDA) on Monday approved Guardant Health’s Shield blood test for colon cancer screening. Although it doesn’t replace colonoscopies, doctors are optimistic it might improve screening rates for the second-highest cause of cancer death in the US, according to NBC News. Shield had been available for $895, but FDA approval means … Read more
